LONG-TERM FOLLOW-UP [hlca]    
Chronic hepatitis C [dsyn]    
Patients [podg]    
Treated [ftcn]    
CIRRHOSIS [dsyn]    
HEPATOCELLULAR CARCINOMA [neop]    
Single [popg]    
Centre [spco]    
YEARS [tmco]    
objectives [inpr]    
Based [ftcn]    
therapy [ftcn]    
Chronic hepatitis C [dsyn]    
CHC [gngm]    
Cost Effectiveness [qnco]    
Reduced [qlco]    
Disease Progression [patf]    
CIRRHOSIS [dsyn]    
HEPATOCELLULAR CARCINOMA [neop]    
Risk Factors [qnco]    
Disease Progression [patf]    
Methods [inpr]    
reviewed [inpr]    
CHC [gngm]    
Patients [podg]    
Registered [hlca]    
About [qlco]    
Patients [podg]    
RECEIVED [qlco]    
Antiviral [phsu]    
treatment [ftcn]    
YEAR [tmco]    
Cumulative [qlco]    
CIRRHOSIS [dsyn]    
LOWER [spco]    
Patients [podg]    
RECEIVED [qlco]    
Antiviral Therapy [topp]    
Patients [podg]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
LOWER [spco]    
CIRRHOSIS [dsyn]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Proportional [qlco]    
Hazards [qlco]    
Regression [patf]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Independent [idcn]    
Reducing [qlco]    
CIRRHOSIS [dsyn]    
Hazard Ratio [qnco]    
YEAR [tmco]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Higher [qlco]    
Patients [podg]    
Receive [qlco]    
Antiviral Therapy [topp]    
CIRRHOSIS [dsyn]    
Independent [idcn]    
Risk Factor [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
0.010" [qnco]    
Conclusions [idcn]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
secondary [neop]    
Based [ftcn]    
therapy [ftcn]    
CIRRHOSIS [dsyn]    
CHC [gngm]    
Patients [podg]    
CIRRHOSIS [dsyn]    
Strong [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
AG [geoa]    
Basel [hcro]    
